Skip to main content

NOMURA HOLDINGS INC

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1163653 TOKYO, M0

Position in APLS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
16 quarters on record

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Derivatives in APLS

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
59,800
PutValue
$0
PutShares
59,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NOMURA HOLDINGS INC holds $218,808,046 across 46 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 59,800
2026-03-31 59,800
2025-12-31 110,100
2025-12-31 110,100
2025-12-31 14,200
2025-09-30 36,600
2025-09-30 116,500
2025-09-30 104,000
2024-12-31 7,000
2023-12-31 12,400
2023-12-31 14,695
2023-06-30 31,186
2023-06-30 97,200
2022-12-31 59,465
2022-09-30 56,170
2022-03-31 104,067
2021-12-31 13,491
2021-09-30 284,500
2021-06-30 46,500
2021-03-31 14,000
2020-12-31 21,300
2020-06-30 8,500
2020-03-31 154,000